Decreased phenytoin levels in antineoplastic therapy.

Decreased Rivaroxaban Levels in a Patient with Cerebral Vein Thrombosis Receiving Phenytoin.

Letter: Serum-phenytoin levels.

Decreased phenytoin level after carboplatin treatment.

Serum-phenytoin levels in management of epilepsy.

Variations in the Blood Phenytoin Levels during Long-Term Combined Treatment with S-1 and Phenytoin.

Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes.

Letter: Word reversal during phenytoin therapy.

Late-onset thrombocytopenia with phenytoin therapy.

Torsades de pointes therapy with phenytoin.

Effectiveness of prednisolone during phenytoin therapy.

Changes in serum immunoglobulin levels during phenytoin treatment of epilepsy.

ABC of monitoring drug therapy. Phenytoin.

[albumin] ratios. Potential errors with hypoalbuminemia.

Decreased circulating anandamide levels in preeclampsia.

Dental anomalies in children submitted to antineoplastic therapy.

Anti-retroviral therapy is associated with decreased alveolar glutathione levels even in healthy HIV-infected individuals.

Decreased serum nesfatin-1 levels in endometriosis.

Melatonin levels are decreased in rheumatoid arthritis.

Late effects of antineoplastic therapy on the developing dentofacial complex.

Comparison of serum phenytoin levels in epileptic patients who swallowed their phenytoin tablets with or without previous chewing.

Decreased plasma protein binding of phenytoin in patients on valproic acid.

Partial responses to antineoplastic drug therapy: what do they mean?

Antiepileptic therapy with phenytoin: which is the optimum serum level?

The effects of toxic and non-toxic serum phenytoin levels on carbohydrate tolerance and insulin levels.

Suggest Documents

Decreased Rivaroxaban Levels in a Patient with Cerebral Vein Thrombosis Receiving Phenytoin.

Letter: Serum-phenytoin levels.

Decreased phenytoin level after carboplatin treatment.

Serum-phenytoin levels in management of epilepsy.

Variations in the Blood Phenytoin Levels during Long-Term Combined Treatment with S-1 and Phenytoin.

Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes.

Letter: Word reversal during phenytoin therapy.

Late-onset thrombocytopenia with phenytoin therapy.

Torsades de pointes therapy with phenytoin.

Effectiveness of prednisolone during phenytoin therapy.

Changes in serum immunoglobulin levels during phenytoin treatment of epilepsy.

ABC of monitoring drug therapy. Phenytoin.

[albumin] ratios. Potential errors with hypoalbuminemia.

Decreased circulating anandamide levels in preeclampsia.

Dental anomalies in children submitted to antineoplastic therapy.

Anti-retroviral therapy is associated with decreased alveolar glutathione levels even in healthy HIV-infected individuals.

Decreased serum nesfatin-1 levels in endometriosis.

Melatonin levels are decreased in rheumatoid arthritis.

Late effects of antineoplastic therapy on the developing dentofacial complex.

Comparison of serum phenytoin levels in epileptic patients who swallowed their phenytoin tablets with or without previous chewing.

Decreased plasma protein binding of phenytoin in patients on valproic acid.

Partial responses to antineoplastic drug therapy: what do they mean?

Antiepileptic therapy with phenytoin: which is the optimum serum level?

The effects of toxic and non-toxic serum phenytoin levels on carbohydrate tolerance and insulin levels.

Decreased phenytoin levels in antineoplastic therapy.

Recommend Documents

Follow Us